Denosumab for the treatment of primary pediatric osteoporosis. Anastasilakis AD, Makras P, Doulgeraki A, Polyzos SA, et al. Osteoporos Int 2021 May 13. pii: 10.1007/s00198-021-06002.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anastasilakis AD, Makras P, Doulgeraki A, Polyzos SA, et al. Denosumab for the treatment of primary pediatric osteoporosis. Osteoporos Int 2021 May 13. pii: 10.1007/s00198-021-06002.
PMID: 33987688